Advertisement

Topics

Latest "Bard" News Stories

03:17 EST 25th February 2018 | BioPortfolio

Here are the most relevant search results for "Bard" found in our extensive news archives from over 250 global news sources.

More Information about Bard on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Bard for you to read. Along with our medical data and news we also list Bard Clinical Trials, which are updated daily. BioPortfolio also has a large database of Bard Companies for you to search.

Showing "Bard" News Articles 1–25 of 237

Relevant

Stock Review for Medical Supplies Investors -- C.R. Bard, Glaukos, Waters, and Cooper

www.wallstequities.com/registration C.R. Bard Murray Hill, New Jerseyheadquartered C.R. Bard Inc.'s stock finished Thursday's session 0.35% lower at $331.40with a total trading volume of Read more...


$24B deal to buy C.R. Bard finalized by Becton Dickinson

The $24 billion acquisition of C.R. Bard has been completed by Becton Dickinson, making Bard its wholly owned subsidiary.  -More- 

C.R. Bard Declares Quarterly Dividend

MURRAY HILL, N.J.--(BUSINESS WIRE)--The Board of Directors of C. R. Bard, Inc. (NYSE-BCR) today declared a regular quarterly dividend of 26 cents per share on Bard's common stock. In connection with the pending merger with Becton, Dickinson & Company, the quarterly dividend will be payable on December ...


Bard acquires female external catheter company PureWick for $30mm

CR Bard Inc. acquired private non-invasive female urological drainage device maker PureWick Inc. for up to $30mm.

BD Statement On MOFCOM Clearance Of Bard Acquisition

"MOFCOM clearance was the final regulatory approval needed to complete the Bard acquisition," said Vincent A. Forlenza, chairman and CEO of BD. "We look Read more...

China OKs Becton Dickinson's $24B C. R. Bard takeover

Becton Dickinson received approval from China's Ministry of Commerce for its proposed $24 billion acquisition of C. R. Bard.  -More- 

Extension of tender offer for Bard notes announced by BD

A tender offer for up to $1.1 billion in outstanding C. R. Bard notes has been extended again by Becton Dickinson from Oct.  -More- 

Merit Medical Coughs Up $100M for Bard, BD's Biopsy Assets

Merit's proposed asset acquisition is subject to the closing of BD’s proposed acquisition of Bard as well as other closing conditions.

BD completes acquisition of medical technology firm C. R. Bard

Becton, Dickinson and Company (BD) has completed the acquisition of US medical technology firm C. R. Bard for about $24bn.

BD completes acquisition of medical technology firm Bard

Becton, Dickinson and Company (BD) has completed the acquisition of US medical technology firm C. R. Bard for about $24bn.

Tender offer for C.R. Bard notes extended again by BD

A tender offer for up to $1.1 billion worth of outstanding C. R. Bard notes was extended again by Becton Dickinson from Nov.  -More- 

C. R. Bard note tender offer extended again by Becton Dickinson

A tender offer for up to $1.1 billion in outstanding C. R. Bard notes was extended again by Becton Dickinson from Dec.  -More- 

C. R. Bard, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 15102017] Prices from USD $350

C. R. Bard, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's C. R. Bard, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investments report includes business description, detailed reports on mergers and acquisitions MA, divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by C. R. Ba...

C. R. Bard, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 13062017] Prices from USD $350

C. R. Bard, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's C. R. Bard, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investments report includes business description, detailed reports on mergers and acquisitions MA, divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by C. R. Ba...

Merit Medical - Becton And Bard Deal Looks Nice

Dividend Aristocrats In Focus Parts 25 And 26: Becton, Dickinson And C.R. Bard

Dividend Aristocrats In Focus Parts 25 And 26: Becton Dickinson And C.R. Bard

Bard Peripheral Vascular Named Arizona BioIndustry Association Of The Year

  Life Sciences Jobs   ...

Respected NYC Dermatologist Comments on New Research into Melanoma

Dr. Susan Bard, one of the top dermatologists and Mohs surgeons in Manhattan frequently sees people with skin cancer. Based on results from two international drug trials a combination of new treatments could halt the progression of melanoma, preventing it from spreading to other organs. New York, NY (PRWEB) September 26, 2017 Dr. Susan Bard, one of the top dermatologists and Mohs surgeons in Manh...

EU grants conditional nod for BD's $24B Bard acquisition

The European Commission gave Becton Dickinson antitrust approval for its $24 billion acquisition of C.R.  -More- 

BD Announces Extension of Exchange Offers and Consent Solicitations for C. R. Bard, Inc. Notes

As of 5:00 p.m., New York Citytime, on December 14, 2017, the following principal amounts of the BD Notes had been validly Read more...

Probably Relevant

Comparable Historical Revenue Schedules Inclusive of C. R. Bard Posted to BD Website

About BD BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical Read more...

FTC clears Becton Dickinson's $24B C. R. Bard acquisition

The Federal Trade Commission cleared Becton Dickinson's proposed $24 billion acquisition of C. R.  -More- 

Merit acquires needle biopsy products from BD

As part of Becton Dickinson & Co.'s purchase of CR Bard Inc., the company divested various soft tissue needle biopsy devices ...

EU concessions for $24B Bard deal submitted by Becton Dickinson

The European Commission said concessions were submitted by Becton Dickinson to address EU antitrust issues concerning its pro -More- 


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks